Supernus Pharma (SUPN) Tops Q3 EPS by 11c; Lowers FY Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| SUPERNUS PHARM (NASDAQ: SUPN) | Delayed: 41.92 +0.08 (0.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $41.84 | 52 Week High | $26.84 | |||
| Open | $42.07 | 52 Week Low | $9.51 | |||
| Day High | $43.72 | P/E | N/A | |||
| Day Low | $39.53 | EPS | $-2.62 | |||
| Volume | 2,818,872 | |||||
